Novaptech is a biotech company internationally renowned for its expertise in aptamers-synthetic oligonucleotides displaying antibody-like properties. Novaptech carries out R&D projects for its customers worldwide, in the pharma and life sciences areas, for therapeutic and diagnostic applications. It also designs aptamer-based biosensors and tests in the frame of its in-house R&D programs.
In the frame of WP6 Novaptech will select, characterise, optimise and functionalise aptamers to 6 new diagnostic biomarkers for the identification and quantification of pathogens and immune responses in fish: unculturable selected pathogens (CEV), slow growing (Flavobacterium) or unidentified (MLO), and immune parameters for which markers are not available are IgT, SCOCS3 and cathelocidin 1.
Chief Scientific Officer of Novaptech – Aptamer Expert
jean-jacques.toulme@inserm.fr
President of Novaptech – Legal representative of the company
marine.laville@novaptech.com